https://www.cochrane.org/ru/evidence/CD004900_botulinum-toxin-type-people-involuntary-eyelid-closure-or-blepharospasm
Botulinum toxin type A for people with involuntary eyelid closure, or blepharospasm | Cochrane
botulinum toxin type a
https://www.scirp.org/journal/PaperInformation?paperID=80334&
Therapeutic Outcome of Botulinum Toxin Type A for Patients with Low Bladder Compliance Secondary to...
Discover the efficacy and safety of BTX-A in treating low bladder compliance secondary to SCI. Results show significant improvements in urodynamic parameters....
botulinum toxin type a
https://www.cochrane.org/de/evidence/CD003633_treatment-botulinum-toxin-type-people-involuntary-posturing-head-or-cervical-dystonia
Treatment with botulinum toxin type A for people with involuntary posturing of the head, or...
botulinum toxin type a
https://www.cochrane.org/ms/evidence/CD004900_botulinum-toxin-type-people-involuntary-eyelid-closure-or-blepharospasm
Botulinum toxin type A untuk orang dengan penutupan kelopak mata yang tidak disengajakan, atau...
botulinum toxin type a
https://www.scirp.org/journal/PaperInformation?PaperID=80334&
Therapeutic Outcome of Botulinum Toxin Type A for Patients with Low Bladder Compliance Secondary to...
Discover the efficacy and safety of BTX-A in treating low bladder compliance secondary to SCI. Results show significant improvements in urodynamic parameters....
botulinum toxin type a
https://pmc.ncbi.nlm.nih.gov/articles/PMC4192970/
Acrylamide inhibits nerve sprouting induced by botulinum toxin type A - PMC
Botulinum toxin type A is a potent muscle relaxant that blocks the transmission and release of acetylcholine at the neuromuscular junction. Intramuscular...
botulinum toxin type aacrylamidenervesproutinginduced
https://www.cochrane.org/hr/evidence/CD003633_treatment-botulinum-toxin-type-people-involuntary-posturing-head-or-cervical-dystonia
Treatment with botulinum toxin type A for people with involuntary posturing of the head, or...
botulinum toxin type a
https://pmc.ncbi.nlm.nih.gov/articles/PMC4335729/
Efficacy of Botulinum Toxin Type A for Treating Chronic Low Back Pain - PMC
Low back pain is a major cause of disability and can result in substantial morbidity and high healthcare costs. Botulinum toxin has been used successfully to...
botulinum toxin type achronic low back pain
https://www.adnkronos.com/immediapress/eng/worlds-first-recombinant-botulinum-toxin-type-a-new-drug-received-marketing-approval-in-china-a-technological-revolution-pioneered-by-claruvis-pharmaceutical_2iZTPSY6m320CIZaI9T71z
World's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a...
CHONGQING, China, April 28, 2026 /PRNewswire/ -- Chongqing Claruvis Pharmaceutical Co., Ltd. recently announced that the China's National Medical Products...
botulinum toxin type a
https://www.sciencedaily.com/releases/2004/02/040209074436.htm
New Data Show Botulinum Toxin Type A To Be Highly Effective Treatment For Excessive Sweating |...
Results of a Phase III clinical study using botulinum toxin type A to treat primary axillary hyperhidrosis, or excessive underarm sweating, show that botulinum...
botulinum toxin type a
https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=57474&ver=29
Article - Billing and Coding: Botulinum Toxin Type A & Type B (A57474)
botulinum toxin type abilling and codingarticle